Eczema Support protocol

Eczema Support

skin conditionsmoderate evidence

About this protocol

Atopic dermatitis (eczema) is a chronic, relapsing inflammatory skin disease affecting 10-20% of children and 1-3% of adults. The pathology is a tripod: skin barrier dysfunction (often driven by filaggrin gene mutations), Th2-skewed immune dysregulation, and an altered skin microbiome with reduced diversity and Staphylococcus aureus overgrowth. Flares cycle around triggersirritants, allergens, stress, infection, dry climateand conventional treatment is rightly aggressive in moderate-to-severe disease: daily emollients, topical corticosteroids and calcineurin inhibitors (tacrolimus, pimecrolimus), and for refractory or extensive disease, biologics like dupilumab. Supplements occupy a supportive role here. They can blunt systemic inflammation, support barrier function, and nudge immune balancebut they don't replace the topical and systemic backbone. If your eczema is moderate-to-severe, scarring you, disrupting sleep, or unresponsive to good topical caresee a dermatologist. Modern biologics (dupilumab, tralokinumab) have transformed outcomes for adult atopic dermatitis. Supplements work best as one layer of a multi-modal plan that always includes daily emollient routine and trigger management.

Where to start

Emollients are the foundation, not the supplements. A daily moisturizer routine applied within 3 minutes of bathing is the single most evidence-based daily action for eczema. Supplements layer on top of thisnot instead of.

Start with omega-3 EPA/DHA at 2 g combined daily. Anti-inflammatory effect builds over 8-12 weeks. EPA-dominant formulations preferred for inflammatory skin endpoints.

Add vitamin D3 at 1000-2000 IU/day, higher if blood levels are deficient (most eczema patients are). Aim for serum 25(OH)D of 40-60 ng/mL. Trial evidence supports SCORAD improvement in deficient patients.

Consider zinc (15-30 mg/day) — required for skin barrier protein synthesis and immune function. More relevant when serum zinc is low; routine supplementation in zinc-replete adults has thinner evidence.

Consider a targeted probioticLactobacillus rhamnosus GG and Bifidobacterium lactis have the strongest trial signal, especially in children and in pregnant/breastfeeding mothers for prevention of atopy. Effect in established adult eczema is smaller.

Treat evening primrose oil (GLA) as exploratory. The 2013 Cochrane review found no significant effect over placebo. Some individuals seem to respondbut the marketing oversells the evidence.

Re-evaluate at 12 weeks. If you're flaring less, sleeping better, and itching lesscontinue. If unchanged, the bottleneck is likely topical/biologic rather than supplemental; see a dermatologist.

5 nutrients

Start here

Strongest evidence — the foundation of the stack.

Omega-3 (EPA-dominant fish oil)

2 g combined EPA+DHA daily (EPA-dominant), with a fat-containing meal
morningwith food

Omega-3 EPA/DHA reduces pro-inflammatory eicosanoid production (PGE2, leukotrienes) and Th2-skewing implicated in atopic dermatitis. Adult RCT evidence (Koch 2008 DHA trial; earlier Søyland 1994; Mayser 2002 IV n-3) supports modest improvement in eczema severity scores. EPA-dominant formulations are preferred for inflammatory endpoints. The effect is real but modestpair with emollients, not substitute.[1, 2, 3, 4]

Vitamin D3 (Cholecalciferol)

1000-2000 IU daily; higher (4000 IU) if serum 25(OH)D is deficient
morningwith food

Eczema patients are commonly vitamin D deficient, and observational data link low 25(OH)D to disease severity. Camargo 2014 RCT in Mongolian children with winter-related atopic dermatitis showed clinically meaningful EASI improvement with 1000 IU/day for 1 month. Effect is greater in deficient than replete patients. Target serum 40-60 ng/mL. Pair with K2 if taking long-term and not getting D from food.[5, 6]

Add if needed

Add these only if the foundation isn't enough.

Probiotic (L. rhamnosus GG + B. lactis)

5-10 billion CFU daily of L. rhamnosus GG (often combined with B. lactis)
morningempty stomach

Strain-specific evidence: Lactobacillus rhamnosus GG (Kalliomäki 2003 4-year follow-up) reduced eczema incidence in at-risk infants when given perinatally. Bifidobacterium lactis trials also signal benefit. The 2018 Cochrane update (Makrgeorgou) found that established treatment effect in adult eczema is small and clinically uncertain, but the prevention signal in maternal/infant use is more robust. Strongest case: pregnancy + breastfeeding in atopy-risk families, or pediatric eczema. Adult established eczema: weaker evidence.[7, 8, 9]

Zinc (Picolinate or Gluconate)

15-30 mg elemental daily, with breakfast
morningwith food

Zinc is required for keratinocyte function, skin barrier protein synthesis, and Th1/Th2 immune balance. The Gray 2019 systematic review found serum zinc was lower in atopic dermatitis patients than controls, and supplementation in deficient patients yielded improvement. Routine zinc supplementation in zinc-replete adults has weaker evidencemost useful when intake or serum levels are low. Don't exceed 30 mg/day chronically without copper.[10, 11]

Experimental

Emerging evidence — try last, only if curious.

Evening Primrose Oil (GLA)

500-1000 mg evening primrose oil (providing ~50-100 mg GLA) twice daily, with food
eveningwith food

Gamma-linolenic acid is a precursor to anti-inflammatory prostaglandin E1. Older trials suggested benefit, but the 2013 Cochrane review (Bamford et al., 27 trials, 1596 participants) concluded that oral EPO and borage oil lack effect on eczema compared with placebo. Treat this as the most speculative itemsome individuals do report symptomatic benefit, but on average the marketing overstates the evidence. Skip if you're not seeing clear benefit at 12 weeks.[12, 13]

Warnings

Do not take with: Anticoagulants and antiplatelets (omega-3 at high doses may modestly increase bleeding risk). Immunosuppressants and biologics like dupilumab (probiotics in profoundly immunocompromised patients carry a small bacteremia riskdiscuss with prescriber). Topical and oral retinoids (vitamin A is fat-soluble; avoid stacking supplemental vitamin A on top of prescription retinoid therapy).
Do not take if: You are profoundly immunocompromised (chemotherapy, post-transplant, advanced HIV) — discuss probiotic use with your oncology/transplant team first. You are pregnant or breastfeeding (omega-3, vitamin D, and specific probiotic strains are generally considered safe and often beneficial, but evening primrose oil in pregnancy is debateddiscuss with your obstetrician). You have moderate-to-severe eczema needing biologic therapy (dupilumab, tralokinumab) — these supplements are complementary, not a substitute. You have a known fish or shellfish allergy (use algal-derived omega-3). Severe widespread eczema with secondary infection needs medical evaluation, not supplements alone.

Lifestyle improvements

Daily emollient routine — the actual foundation

Apply a fragrance-free, ceramide-containing moisturizer at least twice daily, including within 3 minutes of bathing while skin is still damp. This is the single most evidence-based daily action for atopic dermatitismore impactful than any supplement on this stack. Look for products with ceramides, glycerin, petrolatum, or colloidal oatmeal. "Soak and seal" beats "moisturize when you remember."

Lukewarm baths, not hot showers

Hot water strips skin lipids and triggers itch. Lukewarm 10-minute baths or showers, gentle pat-dry, immediate emollient. Adding a quarter-cup of plain bleach to a full bath (dilute bleach bath, 2-3x/week) is dermatologist-recommended for patients with frequent Staphylococcus aureus colonization and recurrent flares.

Identify and remove triggers

Keep a flare diary for 4-8 weeks. Common triggers: wool and synthetic fabrics, fragranced detergents and soaps, dust mites, pollen, pet dander, sweat from exercise, certain foods (in a minoritydon't blanket-eliminate without dietitian guidance), and stress. The pattern matters more than the average.

Cotton and loose clothing

Wool and rough synthetics directly irritate atopic skin. Cotton, bamboo, and silk are gentler. Wash new clothing before wearing. Use fragrance-free, dye-free laundry detergent.

Skip harsh soaps and over-cleansing

Use a fragrance-free, non-soap synthetic cleanser ("syndet" bars or liquids) only where you need it (armpits, groin, feet) — not all over. Over-cleansing strips the already-impaired barrier. No bubble baths, no harsh exfoliants, no fragranced body washes.

Address stress and sleep

Stress is one of the most consistently reported flare triggers, and itch-induced sleep disruption creates a vicious cycle that further dysregulates immunity. Daily breathwork, CBT for chronic itch, and treating sleep disruption (sometimes with a sedating antihistamine at night under physician guidance) compound with the stack.

Humidify in winter

Winter low-humidity environments worsen barrier dysfunction. A bedroom humidifier targeting 40-50% relative humidity helps many patientsthe Camargo 2014 trial was specifically in winter-related eczema for a reason.

Consider dupilumab or other biologics for moderate-to-severe disease

If you've maximized topical therapy and still have significant disease (sleep disruption, persistent itch, large body surface involvement, impact on work/quality of life) — ask your dermatologist about dupilumab (Dupixent), tralokinumab, or JAK inhibitors. These have transformed outcomes for adult atopic dermatitis. Supplements are complementary; biologics are the modern backbone for refractory disease.

Patch test for contact dermatitis

If your eczema looks atypical, localized, or treatment-resistantrequest patch testing. Allergic contact dermatitis (nickel, fragrance, preservatives) commonly coexists with or mimics atopic dermatitis and demands a different management approach.

Address the gut-skin axis carefully

The gut microbiome plausibly influences atopic disease, but evidence for specific elimination diets in established adult eczema is weak. Don't undertake aggressive food eliminations without a registered dietitian. Probiotic supplementation (above) is more evidence-based than food elimination for most adults.

References

  1. Fish oil — supplement research overviewExamine.com link
  2. Koch C, et al. Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial. Br J Dermatol. 2008;158(4):786-792.PubMed link
  3. Søyland E, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol. 1994;130(6):757-764.PubMed link
  4. Jia Y, et al. Effect of Prenatal Omega-3 Polyunsaturated Fatty Acid Supplementation on Childhood Eczema: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2023;184(1):21-32.PubMed link
  5. Vitamin D — supplement research overviewExamine.com link
  6. Camargo CA Jr, et al. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol. 2014;134(4):831-835.PubMed link
  7. Probiotics — supplement research overviewExamine.com link
  8. Kalliomäki M, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361(9372):1869-1871.PubMed link
  9. Makrgeorgou A, et al. Probiotics for treating eczema. Cochrane Database Syst Rev. 2018;11(11):CD006135.PubMed link
  10. Zinc — supplement research overviewExamine.com link
  11. Gray NA, et al. Zinc and atopic dermatitis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019;33(6):1042-1050.PubMed link
  12. Evening primrose oil — supplement research overviewExamine.com link
  13. Bamford JTM, et al. Oral evening primrose oil and borage oil for eczema. Cochrane Database Syst Rev. 2013;(4):CD004416.PubMed link
  14. Stefanovic N, Irvine AD. Filaggrin and beyond: New insights into the skin barrier in atopic dermatitis and allergic diseases. Ann Allergy Asthma Immunol. 2024;132(2):187-195.PubMed link
  15. Simpson EL, et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis (SOLO 1 and SOLO 2). N Engl J Med. 2016;375(24):2335-2348.PubMed link

Related protocols

Other skin conditions protocols and protocols sharing ingredients with this one.

Psoriasis Support

skin conditions

Psoriasis is a chronic, immune-mediated inflammatory disease affecting 2-3% of adults. The hallmark is accelerated keratinocyte turnover — skin cells replicating every 3-5 days instead of the normal 28-30 — driven by a Th17/IL-23 immune axis. Clinically that shows up as well-demarcated red plaques with silvery scale, classically on the elbows, knees, scalp, and lower back. Psoriasis is not just a skin disease: it carries substantial comorbid risk. Roughly 30% of patients develop psoriatic arthritis, and the cohort as a whole runs higher cardiovascular disease, metabolic syndrome, and depression rates than the general population. Treatment is genuinely multi-modal — topical corticosteroids and vitamin D analogs (calcipotriol) for limited disease, phototherapy for wider involvement, and systemic biologics targeting IL-17 (secukinumab/Cosentyx), IL-23 (risankizumab/Skyrizi, guselkumab/Tremfya, ustekinumab/Stelara), or TNF-alpha (adalimumab/Humira) for moderate-to-severe disease. If you have moderate-to-severe psoriasis — significant body surface area, scalp/genital/palmar-plantar involvement, joint symptoms, or quality-of-life impact — see a dermatologist. The biologics era has been transformative; PASI 90 (90% lesion clearance) is now a realistic goal for most patients, not the exception. Supplements occupy a supportive role: they can blunt systemic inflammation, correct deficiencies that worsen disease activity, and address the cardiometabolic comorbidity burden. They don't replace appropriate dermatologic care for anything beyond mild localized disease.

Rosacea Support

skin conditions

Rosacea is a chronic inflammatory facial dermatosis affecting roughly 5% of adults — disproportionately women aged 30-60 with fair skin (Fitzpatrick I-II), though it occurs across all skin types and is frequently underdiagnosed in darker skin. It presents as four overlapping phenotypes: erythematotelangiectatic (persistent central facial redness with visible vessels), papulopustular (acne-like inflammatory papules and pustules), phymatous (skin thickening and tissue overgrowth, most often on the nose), and ocular (dry, gritty, inflamed eyes — frequently missed because patients see ophthalmology and dermatology separately). The pathology is multifactorial: dysregulated innate immunity via the cathelicidin/LL-37 pathway, mast cell activation, neurovascular hyperresponsiveness, and Demodex folliculorum mite overgrowth all interact. The first-line conventional toolkit — topical metronidazole, ivermectin (Soolantra), azelaic acid, and brimonidine; oral sub-microbial doxycycline; isotretinoin for refractory phymatous disease — is genuinely effective and should not be skipped in favor of supplements. Supplements occupy a narrower supportive role here than in eczema or psoriasis. The trial evidence is thinner, and the most impactful daily actions are trigger identification, photoprotection, and gentle skincare — not a pill regimen. We've included supplements with at least some direct rosacea evidence (oral zinc, niacinamide) plus a few with strong mechanistic rationale (omega-3 for ocular subtype, quercetin for mast cell stabilization). If your rosacea is moderate-to-severe, scarring, or involves the eyes, see a dermatologist (and an ophthalmologist for ocular involvement) — topical ivermectin and oral doxycycline transformed outcomes in the last decade and remain the backbone of treatment.

Fibromyalgia Support

chronic illness· 2 shared ingredients

Fibromyalgia is a real, frequently-dismissed condition affecting an estimated 2-4% of adults — predominantly women between 30 and 60. Its core features are chronic widespread musculoskeletal pain, fatigue, cognitive dysfunction (commonly called "fibro fog"), non-restorative sleep, and frequent comorbidities including IBS, anxiety, and depression. The dominant pathophysiologic model is central sensitization — the central nervous system amplifies pain signals — and a subset of patients also show small-fiber neuropathy on skin biopsy. Mitochondrial dysfunction and oxidative stress are increasingly documented in the fibromyalgia literature. CRITICAL: This protocol is ADJUNCTIVE. Fibromyalgia management is multi-modal, and supplements are one part of a larger plan. Conventional medications (duloxetine, pregabalin, amitriptyline, milnacipran), cognitive behavioral therapy adapted for fibromyalgia (CBT-FM), gentle aerobic exercise as tolerated, and aggressive sleep optimization all have stronger evidence individually than any supplement. That said, fibromyalgia is one of the few chronic pain conditions where supplements have notable trial backing — magnesium malate, CoQ10, vitamin D, and SAMe each have randomized data. If you haven''t had a rheumatology or pain-medicine evaluation, that should come first.

Track this protocol in Pilora

Add these supplements to your shelf, get smart dose reminders, and check for interactions — all in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This protocol is educational, not a substitute for personalized medical advice. Talk to your doctor before starting any new supplement regimen — especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition. Last updated 5/20/2026.